Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhenqian Huang
Observed names:
Zhen-Qian Huang,
Zhen-qian Huang,
ZhenQian Huang
Institution:
First Affiliated Hospital of Guangzhou Medical University
Observed institutions:
First Affiliated Hospital of Guangzhou Medical University,
Wuhan Textile University,
Twelfth Guangzhou City People's Hospital,
Guangzhou Medical University
ORCID:
0009-0005-1677-9340
Observed ORCID:
0009-0005-1677-9340
OpenAlex ID:
A5115593110
USP7 promotes non‐small‐cell lung cancer cell glycolysis and survival by stabilizing and activating c‐Abl
2023
·
Yuanming He
, Shuoyi Jiang
, et al.
·
Clinical and Translational Medicine
·
58
PDF
Hypoxia-induced secretion of IL-10 from adipose-derived mesenchymal stem cell promotes growth and cancer stem cell properties of Burkitt lymphoma
2015
·
Lihua Xu
, Xu Wang
, et al.
·
Tumor Biology
·
40
Suppression of USP7 induces BCR-ABL degradation and chronic myelogenous leukemia cell apoptosis
2021
·
Shuoyi Jiang
, Xiaoge Wang
, et al.
·
Cell Death and Disease
·
38
PDF
Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open‐label study
2023
·
Lijuan Deng
, Zhiming Li
, et al.
·
American Journal of Hematology
·
25
PDF
Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study
2023
·
Dan Xu
, Ying Yang
, et al.
·
Blood Cancer Journal
·
17
PDF
Inhibition of USP10 induces myeloma cell apoptosis by promoting cyclin D3 degradation
2023
·
Yu-jia Xu
, Kun Zeng
, et al.
·
Acta Pharmacologica Sinica
·
17
PDF
Induction of zinc finger protein RNF6 auto-ubiquitination for the treatment of myeloma and chronic myeloid leukemia
2022
·
Haixia Zhuang
, Ying Ren
, et al.
·
Journal of Biological Chemistry
·
16
Induction of IFIT1/IFIT3 and inhibition of Bcl-2 orchestrate the treatment of myeloma and leukemia via pyroptosis
2024
·
Yuanming He
, Shuoyi Jiang
, et al.
·
Cancer Letters
·
15
Induction of CML28-specific cytotoxic T cell responses using co-transfected dendritic cells with CML28 DNA vaccine and SOCS1 small interfering RNA expression vector
2006
·
Hongsheng Zhou
, Donghua Zhang
, et al.
·
Biochemical and Biophysical Research Communications
·
15
Immediate early response 3 gene promotes aggressive progression and autophagy of AML by negatively regulating AKT/mTOR
2023
·
Yimin Chen
, Zhenqian Huang
, et al.
·
Translational Oncology
·
12
Eukaryotic initiation factor-2, gamma subunit, suppresses proliferation and regulates the cell cycle via the MAPK/ERK signaling pathway in acute myeloid leukemia
2021
·
Jielun Lu
, Shuyi Chen
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
12
PDF
Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma
2024
·
Huaqing Wang
, Jifeng Feng
, et al.
·
Signal Transduction and Targeted Therapy
·
11
PDF
Clinical and laboratory features of seven patients with acute myeloid leukemia (AML)-M2/M3 and elevated myeloblasts and abnormal promyelocytes
2014
·
GanLin He
, ChunYan Wang
, et al.
·
Cancer Cell International
·
10
PDF
g-C 3 N 4 nanosheet supported NiCo 2 O 4 nanoparticles for boosting degradation of tetracycline under visible light and ultrasonic irradiation
2024
·
Qingfeng Guo
, Changwang Yan
, et al.
·
Nanoscale
·
9
PDF
Acevaltrate overcomes myeloma resistance to bortezomib via pyroptosis by promoting BAX translocalization to mitochondria
2025
·
Yaner Wang
, Yaoli Cui
, et al.
·
European Journal of Pharmacology
·
8
RNF6 Inhibits Lung Adenocarcinoma Cell Proliferation by Promoting Cyclin D2 Degradation
2025
·
Yuening Sun
, Liyang Jiang
, et al.
·
Molecular Cancer Research
·
5
Venetoclax plus a hypomethylating agent versus cytarabine, aclarubicin, and granulocyte colony‐stimulating factor chemotherapy as a first‐line therapy for newly diagnosed acute myeloid leukemia: A propensity score–matched analysis
2024
·
Rui Huang
, Honghua He
, et al.
·
Cancer
·
5
PDF
Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial
2023
·
Huixing Zhou
, Yafei Wang
, et al.
·
Annals of Hematology
·
2
PDF
IFI27 and BAX are Essential for GSDME‐Mediated Myeloma Cell Pyroptosis
2026
·
Yaoli Cui
, Yuening Sun
, et al.
·
Advanced Science
·
1
PDF
ABC Regimen (Azacitidine, Venetoclax and Chidamide) Is Comparable to the “3+7” Regimen in Newly Diagnosed AML: A Real-World Experience from South China
2023
·
Jianyu Weng
, Xin Huang
, et al.
·
Blood
·
1
Evaluation of physician guideline adherence and areas for improvement in managing patients with chronic myeloid leukemia: a cross-sectional survey
2023
·
Hong Chen
, Yuming Zhang
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
1
Construction of HA-1-DC nucleic-acid vaccine and induction of specific cytotoxic T lymphocytes
2007
·
Yaya Wang
, Donghua Zhang
, et al.
·
Journal of Huazhong University of Science and Technology [Medical Sciences]
·
1
Construction and expression of dendritic cell nucleic acid vaccine containing CML28 gene in human dendritic cells.
2005
·
Dong-Hua Zhang
, Hong-Sheng Zhou
, et al.
·
PubMed
·
1
Real-world treatment patterns and outcomes of brentuximab vedotin–based therapy in CD30-positive lymphomas in China: the prospective BRAVE study
2026
·
Ming-Ci Cai
, Ou Bai
, et al.
·
Blood Cancer Journal
PDF
POSTER: ALL-741: Olverembatinib-Based Treatment for Newly Diagnosed Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Multi-Center Retrospective Study
2026
·
Kezhi Huang
, Yiqing Li
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Show more works
View as search
Works count:
65
Citation count:
320
H-index:
11
I10-index:
13
Year
Topic
Type